HOME > MARKETS > COMPANY NEWS
  COMPANY NEWS
COMPANY
Nectar Lifesciences acquires entire stake in AEPL
Mar-06-2026

Nectar Lifesciences has acquired entire paid-up equity share capital in Avensis Exports (AEPL). The acquisition was made for a total cash consideration of Rs 24.96 lakh and paid through normal banking channels. Following this transfer of shares from existing holders, AEPL has become a wholly owned subsidiary of the company with effect from March 06, 2026. The acquisition of AEPL will help the company to enter into a real estate business.

Earlier, the company had received its board’s approval to acquire 100% paid-up equity share capital of Avensis Exports (AEPL) on March 02, 2026.

Nectar Lifesciences, Incorporated in 1995, is a leading global manufacturer of cephalosporin antibiotics medicines.

  RELATED NEWS >>